COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer

Deijen, Charlotte L.; Velthuis, Simone; Tsai, Alice; Mavroveli, Stella; Klerk, Elly S.M. de Lange–de; Sietses, C.; Tuynman, Jurriaan B.; Lacy, Antonio M.; Hanna, George B.; Bonjer, H. Jaap

doi:10.1007/s00464-015-4615-x

Cited by 317 publications

(223 citation statements)

References 16 publications

Supporting

Mentioning

209

Contrasting

Unclassified

Order By: Relevance

“…The first results demonstrate comparable short-term results for taTME and traditional laparoscopic TME. To improve promising results, the ongoing COLLOR III randomized trial compares taTME and laparoscopic TME for mid and low rectal carcinomas [21].…”

Section: Discussionmentioning

confidence: 99%

Transanalinė totalinė mezorektalinė ekscizija (taTME): pirmoji mūsų patirtis

Mikalauskas¹,

Kryžauskas²,

Jurkevičiūtė³

et al. 2016

View full text Add to dashboard Cite

Transanal total mesorectal excision (taTME) is a new natural orifice translumenal endoscopic surgery modality combined of three rectal surgery techniques. Detailed analysis of the taTME is the object of this article. We submit the report of three taTME procedures for histologically confirmed rectal adenocarcinoma that were performed for the first time in Lithuania, Vilnius University Hospital Santariskiu Klinikos.Key words: taTME, rectal surgery, minimally invasive surgery Transanalinė totalinė mezorektalinė ekscizija (taTME) yra naujas endoskopinis natūralių angų chirurgijos būdas, susidedantis iš trijų tiesiosios žarnos chirurginių metodų. Šiame straipsnyje detaliai aprašoma taTME chirurginė technika bei pristatomos pirmosios trys taTME procedūros, kurios buvo atliktos Vilniaus universiteto ligoninėje Santariškių klinikose. Reikšminiai žodžiai: taTME, tiesiosios žarnos chirurgija, minimaliai invazinė chirurgija Originalūs mokslo tiriamieji darbai

show abstract

Section: Discussionmentioning

confidence: 99%

Transanalinė totalinė mezorektalinė ekscizija (taTME): pirmoji mūsų patirtis

Mikalauskas¹,

Kryžauskas²,

Jurkevičiūtė³

et al. 2016

View full text Add to dashboard Cite

show abstract

“…A combination of both taTME and RS will likely become a promising strategy in selected patients [59], while prospective randomized trials are needed to prove the advantages of this approach over conventional laTME [60].…”

Section: Resultsmentioning

confidence: 99%

Lower Gastrointestinal Surgery: Robotic Surgery versus Laparoscopic Procedures

et al. 2018

View full text Add to dashboard Cite

Introduction: For a long time, the comprehensive application of minimally invasive techniques in lower gastrointestinal (GI) surgery was substantially impaired by inherent anatomical and technical complexities. Recently, several new techniques such as robotic operating platforms and transanal total mesorectal excision (taTME) have revolutionized the minimally invasive approach. This review aims to depict the current state of the art and evaluates the advantages and drawbacks in regard to perioperative outcome and quality of oncological resection. Methods: A systematic literature search was performed using the search terms ‘colorectal cancer', ‘rectal cancer', ‘minimally invasive surgery', ‘laparoscopic surgery', and ‘robotic' to identify relevant studies reporting on robotic surgery (RS) either alone or in comparison to laparoscopic surgery (LS). Publications on taTME were analyzed separately. Results: 69 studies reporting on RS with a total of 20,872 patients, and 17 articles on taTME including 881 patients, were identified. Conclusion: Both RS and taTME can facilitate a minimally invasive approach for lower GI surgery in an increasing number of patients. Furthermore, combining both techniques might become an auspicious approach in selected patients; further prospective and randomized trials are needed to verify its benefits over conventional laTME.

show abstract

“…Exclusion criteria are T1 tumors that can be treated by local excision, tumors with ingrowth in the internal sphincter or levator ani muscle, and all T4 tumors. All participating centers in the COLOR III trial will keep the coordinating center informed of all patients presenting with rectal cancer [17] . The ETAP-GRECCAR 11 randomized controlled trial is also comparing TaTME to laparoscopic TME.…”

Section: Clinical Trialsmentioning

confidence: 99%

The role of transanal total mesorectal excision in rectal surgery

Yellinek¹,

Wexner²

2018

MIS

View full text Add to dashboard Cite

Transanal total mesorectal excision (TaTME) is the newest approach for the resection of rectal cancer, according to the principles of TME. The evolution of TaTME started almost 40 years ago and is a combination of several important developments in both micro-endoscopic surgery and transanal surgery. The preliminary clinical data have revealed acceptable TME quality. Clinical trials to determine the long-term oncological results are still in process. In order to master TaTME, the surgeon should be an expert in laparoscopic rectal surgery as well as transanal microsurgery and follow a stepwise training approach. Robotic TaTME using a single-port robotic system is a promising future development.

show abstract

COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer

Cited by 317 publications

References 16 publications

Transanalinė totalinė mezorektalinė ekscizija (taTME): pirmoji mūsų patirtis

Transanalinė totalinė mezorektalinė ekscizija (taTME): pirmoji mūsų patirtis

Lower Gastrointestinal Surgery: Robotic Surgery versus Laparoscopic Procedures

The role of transanal total mesorectal excision in rectal surgery

Contact Info

Product

Resources

About